Maravai LifeSciences Holdings, Inc.

NASDAQ:MRVI

8.84 (USD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018
Operating Activities:
Net Income -119.029490.663469.2578.816-5.201-16.915
Depreciation & Amortization 48.78138.10324.75225.83724.08422.347
Deferred Income Tax 754.94242.31846.904-5.464-1.1590.317
Stock Based Compensation 34.58818.6710.45824.6291.6792.121
Change In Working Capital 97.844-45.082-176.63135.8932.29-15.841
Accounts Receivables 84.395-22.272-70.391-33.144-1.888-4.146
Inventory 0.6499.459-21.574-19.0990.1062.311
Accounts Payables 5.284-1.5780.6761.1762.47-0.871
Other Working Capital 7.516-30.691-85.34286.961.602-13.135
Other Non Cash Items -690.902-8.695-6.163-7.5242.4227.785
Operating Cash Flow 126.224535.977368.57152.18724.115-0.186
Investing Activities:
Investments In Property Plant And Equipment -65.553-17.09-14.85-25.408-17.148-3.611
Acquisitions Net -69.622-238.349119.957-3.02400.16
Purchases Of Investments 000000
Sales Maturities Of Investments 000000
Other Investing Activites 12.865-12.1730.54834.500.16
Investing Cash Flow -122.31-267.612105.6556.068-17.148-3.451
Financing Activities:
Debt Repayment -5.772-13.895-6-412.076-2.64-255.202
Common Stock Issued -0.022.3581.7091,758.93200
Common Stock Repurchased -0.0200-1,457.982-0.227-0.009
Dividends Paid 00000-52.056
Other Financing Activities -55.298-175.962-154.758773.659-1.3298.091
Financing Cash Flow -61.09-187.499-159.04953.212-4.167-9.167
Other Information:
Effect Of Forex Changes On Cash 1.6120-0.0880.0170.034-0.069
Net Change In Cash -57.17680.866315.088211.4842.834-12.873
Cash At End Of Period 574.962632.138551.272236.18424.721.866